US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 1.750
  • +0.250+16.67%
Close Apr 25 16:00 ET
16.26MMarket Cap-0.48P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-36.52%-34.29M
29.11%-9.53M
-21.75%-6.29M
-57.53%-7.72M
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
Net income from continuing operations
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
Operating gains losses
-210.63%-5.39M
-51.83%2.31M
96.84%-6.17K
-720.10%-2.22M
-6,521.24%-5.47M
146.74%4.87M
13,183.43%4.79M
75.08%-195.47K
120.66%357.52K
98.95%-82.59K
Depreciation and amortization
27.96%4.79M
-16.80%785.71K
-1.89%966.86K
18.27%1.06M
114.99%1.98M
13.77%3.75M
2.26%944.4K
8.30%985.45K
14.25%892.27K
36.27%923.17K
Other non cash items
-106.39%-237.09K
-100.54%-19.34K
---48.36K
-270.80%-85.4K
-189.80%-83.99K
11,623.32%3.71M
--3.57M
--0
--50K
--93.53K
Change In working capital
-198.83%-2.3M
-340.88%-1.88M
240.24%2.1M
609.17%263.34K
-165.88%-2.77M
1,079.15%2.33M
-108.84%-427.41K
3.33%-1.49M
-94.75%37.13K
199.44%4.21M
-Change in receivables
-100.99%-54.96K
--42.09K
-64.65%127.88K
-107.90%-31.69K
-104.03%-193.23K
126.42%5.56M
--0
110.86%361.74K
-81.53%401.39K
226.95%4.79M
-Change in prepaid assets
-12.77%-590.46K
31.79%-963.01K
-111.21%-25.84K
103.06%687.93K
-190.79%-289.54K
-177.62%-523.61K
-155.56%-1.41M
-74.44%230.56K
-50.14%338.79K
189.93%318.9K
-Change in payables and accrued expense
93.03%-307.71K
-165.51%-849.75K
309.99%1.99M
86.03%-111.71K
66.30%-1.34M
-33.04%-4.42M
161.02%1.3M
-203.00%-947.76K
62.41%-799.85K
-29,207.33%-3.97M
-Change in other current assets
----
----
-96.89%3.99K
-112.79%-18.06K
-108.29%-10.4K
----
----
426.64%128.11K
885.63%141.22K
794.31%125.53K
-Change in other working capital
-178.72%-1.35M
-267.89%-138.16K
--0
-492.42%-263.14K
-132.14%-944.58K
1,809.71%1.71M
--82.29K
---1.27M
---44.42K
3,039.20%2.94M
Cash from discontinued investing activities
Operating cash flow
-36.52%-34.29M
29.11%-9.53M
-21.75%-6.29M
-57.53%-7.72M
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
Investing cash flow
Cash flow from continuing investing activities
-7,733.63%-11.96M
13,849.21%9.33M
-2,721.23%-1.15M
49,556.96%11.22M
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
Net PPE purchase and sale
-120.86%-337.26K
18.40%-55.38K
-145.50%-100.3K
-131.49%-52.51K
-505.98%-129.07K
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
Net investment purchase and sale
---11.63M
--9.39M
---1.05M
--11.27M
---31.23M
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-7,733.63%-11.96M
13,849.21%9.33M
-2,721.23%-1.15M
49,556.96%11.22M
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
Financing cash flow
Cash flow from continuing financing activities
-101.76%-1.17M
-99.68%216.96K
-380.46%-674.13K
11.75%-321.04K
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
Net issuance payments of debt
-132.30%-907K
-49.37%241.9K
-354.77%-649.13K
30.64%-252.33K
31.59%-247.44K
67.05%-390.45K
-32.39%477.76K
50.28%-142.74K
54.54%-363.79K
55.04%-361.68K
Net preferred stock issuance
--0
----
----
----
----
--7.5M
----
----
----
----
Proceeds from stock option exercised by employees
-99.97%20.41K
-100.00%-3
--0
--0
980.00%20.41K
77,414.37%59.66M
5,965,926,300.00%59.66M
242,900.00%2.43K
--0
-75.86%1.89K
Net other financing activities
---286.04K
---24.93K
---25K
---68.71K
---167.39K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-101.76%-1.17M
-99.68%216.96K
-380.46%-674.13K
11.75%-321.04K
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
Net cash flow
Beginning cash position
275.93%56.57M
278.12%9.17M
121.78%17.24M
7.46%14.03M
275.93%56.57M
-61.95%15.05M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
-61.95%15.05M
Current changes in cash
-214.28%-47.43M
-99.97%15.54K
-51.78%-8.12M
160.16%3.18M
-2,039.29%-42.5M
269.40%41.5M
706.03%54.12M
35.43%-5.35M
8.74%-5.29M
88.41%-1.99M
Effect of exchange rate changes
-1,429.35%-241.2K
-1,691.42%-288.75K
--47.54K
--28.28K
---28.27K
--18.14K
--18.14K
--0
--0
--0
End cash Position
-84.27%8.9M
-84.27%8.9M
278.12%9.17M
121.78%17.24M
7.46%14.03M
275.93%56.57M
275.93%56.57M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
Free cash flow
-36.79%-34.63M
29.06%-9.59M
-21.69%-6.39M
-57.87%-7.77M
-568.65%-10.88M
1.21%-25.32M
-707.91%-13.51M
34.31%-5.25M
2.75%-4.92M
85.07%-1.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -36.52%-34.29M29.11%-9.53M-21.75%-6.29M-57.53%-7.72M-569.48%-10.75M-7.08%-25.12M-764.73%-13.45M34.74%-5.17M-10.14%-4.9M83.16%-1.61M
Net income from continuing operations 19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M-125.14%-42.19M-190.26%-22.86M27.89%-5.1M-44.07%-6.88M-845.93%-7.35M
Operating gains losses -210.63%-5.39M-51.83%2.31M96.84%-6.17K-720.10%-2.22M-6,521.24%-5.47M146.74%4.87M13,183.43%4.79M75.08%-195.47K120.66%357.52K98.95%-82.59K
Depreciation and amortization 27.96%4.79M-16.80%785.71K-1.89%966.86K18.27%1.06M114.99%1.98M13.77%3.75M2.26%944.4K8.30%985.45K14.25%892.27K36.27%923.17K
Other non cash items -106.39%-237.09K-100.54%-19.34K---48.36K-270.80%-85.4K-189.80%-83.99K11,623.32%3.71M--3.57M--0--50K--93.53K
Change In working capital -198.83%-2.3M-340.88%-1.88M240.24%2.1M609.17%263.34K-165.88%-2.77M1,079.15%2.33M-108.84%-427.41K3.33%-1.49M-94.75%37.13K199.44%4.21M
-Change in receivables -100.99%-54.96K--42.09K-64.65%127.88K-107.90%-31.69K-104.03%-193.23K126.42%5.56M--0110.86%361.74K-81.53%401.39K226.95%4.79M
-Change in prepaid assets -12.77%-590.46K31.79%-963.01K-111.21%-25.84K103.06%687.93K-190.79%-289.54K-177.62%-523.61K-155.56%-1.41M-74.44%230.56K-50.14%338.79K189.93%318.9K
-Change in payables and accrued expense 93.03%-307.71K-165.51%-849.75K309.99%1.99M86.03%-111.71K66.30%-1.34M-33.04%-4.42M161.02%1.3M-203.00%-947.76K62.41%-799.85K-29,207.33%-3.97M
-Change in other current assets ---------96.89%3.99K-112.79%-18.06K-108.29%-10.4K--------426.64%128.11K885.63%141.22K794.31%125.53K
-Change in other working capital -178.72%-1.35M-267.89%-138.16K--0-492.42%-263.14K-132.14%-944.58K1,809.71%1.71M--82.29K---1.27M---44.42K3,039.20%2.94M
Cash from discontinued investing activities
Operating cash flow -36.52%-34.29M29.11%-9.53M-21.75%-6.29M-57.53%-7.72M-569.48%-10.75M-7.08%-25.12M-764.73%-13.45M34.74%-5.17M-10.14%-4.9M83.16%-1.61M
Investing cash flow
Cash flow from continuing investing activities -7,733.63%-11.96M13,849.21%9.33M-2,721.23%-1.15M49,556.96%11.22M-147,126.32%-31.36M92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K
Net PPE purchase and sale -120.86%-337.26K18.40%-55.38K-145.50%-100.3K-131.49%-52.51K-505.98%-129.07K92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K
Net investment purchase and sale ---11.63M--9.39M---1.05M--11.27M---31.23M--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow -7,733.63%-11.96M13,849.21%9.33M-2,721.23%-1.15M49,556.96%11.22M-147,126.32%-31.36M92.69%-152.7K42.37%-67.86K47.96%-40.86K96.30%-22.68K98.34%-21.3K
Financing cash flow
Cash flow from continuing financing activities -101.76%-1.17M-99.68%216.96K-380.46%-674.13K11.75%-321.04K-9.62%-394.42K6,250.81%66.77M706.40%67.64M51.13%-140.31K50.24%-363.79K94.31%-359.79K
Net issuance payments of debt -132.30%-907K-49.37%241.9K-354.77%-649.13K30.64%-252.33K31.59%-247.44K67.05%-390.45K-32.39%477.76K50.28%-142.74K54.54%-363.79K55.04%-361.68K
Net preferred stock issuance --0------------------7.5M----------------
Proceeds from stock option exercised by employees -99.97%20.41K-100.00%-3--0--0980.00%20.41K77,414.37%59.66M5,965,926,300.00%59.66M242,900.00%2.43K--0-75.86%1.89K
Net other financing activities ---286.04K---24.93K---25K---68.71K---167.39K--------------------
Cash from discontinued financing activities
Financing cash flow -101.76%-1.17M-99.68%216.96K-380.46%-674.13K11.75%-321.04K-9.62%-394.42K6,250.81%66.77M706.40%67.64M51.13%-140.31K50.24%-363.79K94.31%-359.79K
Net cash flow
Beginning cash position 275.93%56.57M278.12%9.17M121.78%17.24M7.46%14.03M275.93%56.57M-61.95%15.05M-70.89%2.43M-53.21%7.77M-41.72%13.06M-61.95%15.05M
Current changes in cash -214.28%-47.43M-99.97%15.54K-51.78%-8.12M160.16%3.18M-2,039.29%-42.5M269.40%41.5M706.03%54.12M35.43%-5.35M8.74%-5.29M88.41%-1.99M
Effect of exchange rate changes -1,429.35%-241.2K-1,691.42%-288.75K--47.54K--28.28K---28.27K--18.14K--18.14K--0--0--0
End cash Position -84.27%8.9M-84.27%8.9M278.12%9.17M121.78%17.24M7.46%14.03M275.93%56.57M275.93%56.57M-70.89%2.43M-53.21%7.77M-41.72%13.06M
Free cash flow -36.79%-34.63M29.06%-9.59M-21.69%-6.39M-57.87%-7.77M-568.65%-10.88M1.21%-25.32M-707.91%-13.51M34.31%-5.25M2.75%-4.92M85.07%-1.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +19.98%
4
NEW JCM GROUP
300157
+19.92%
5
Shenzhen S-king Intelligent Equipment
688328
+15.32%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 284.950
Sample Name
Sample Code
 368.710
Sample Name
Sample Code
 209.640
4
Meta Platforms
META
547.270
5
MARA Holdings
MARA
14.300
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 284.950
Sample Name
Sample Code
 111.010
Sample Name
Sample Code
 547.270
4
Advanced Micro Devices
AMD
96.645
5
Broadcom
AVGO
192.310
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.6030
Sample Name
Sample Code
 3.220
Sample Name
Sample Code
 1.890
4
BTCS Inc
BTCS
1.910
5
Canaan
CAN
0.8330
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -